Three independent discounted-cash-flow-style models value Globus Medical, Inc. every trading day. 0 of 3 currently price GMED above its market price.
| Free Cash Flow model | $16.86 |
| Excess Profit model | $25.41 |
| Residual Earnings model | $1.00 |
| Dividend Discount model | — |
| Piotroski F-Score | 8 / 9 |
| Return on invested capital | +9.0% |
| Net debt / EBITDA | -0.6× |
| Gross margin | +67.4% |
| Revenue CAGR | +42.2% |
| Cash conversion | 1.4× |
| Dividend yield | — |
| Buyback yield | +18.0% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open GMED in StockKitty